| scholarly article | Q13442814 |
| P50 | author | Michael P Rout | Q37385780 |
| P2093 | author name string | Brian T Chait | |
| Yang Luo | |||
| James M Binley | |||
| Ileana M Cristea | |||
| Todd M Greco | |||
| David Fenyö | |||
| Tommy Tong | |||
| Sarah Keegan | |||
| Mark A Muesing | |||
| Kevin D Mohammed | |||
| Erica Y Jacobs | |||
| P2860 | cites work | Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies | Q21090536 |
| Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy | Q22251085 | ||
| Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins | Q24292359 | ||
| Global landscape of HIV-human protein complexes | Q24300336 | ||
| T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction | Q24300389 | ||
| Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 | ||
| Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis | Q24498694 | ||
| Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication | Q24672416 | ||
| The immunological synapse: the gateway to the HIV reservoir | Q27002959 | ||
| 4.0-A resolution cryo-EM structure of the mammalian chaperonin TRiC/CCT reveals its unique subunit arrangement | Q27660079 | ||
| Broad and potent neutralization of HIV-1 by a gp41-specific human antibody | Q27675131 | ||
| Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
| Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex | Q28210666 | ||
| Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes | Q28271300 | ||
| Dynamics of the cellular metabolome during human cytomegalovirus infection | Q28469080 | ||
| The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex | Q28474177 | ||
| 2016 update of the PRIDE database and its related tools | Q28603110 | ||
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Broad neutralization coverage of HIV by multiple highly potent antibodies | Q29615361 | ||
| Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 | ||
| AAA+ proteins: have engine, will work | Q29617410 | ||
| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 | Q29619511 | ||
| A comprehensive functional map of the hepatitis C virus genome provides a resource for probing viral proteins. | Q30367341 | ||
| Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate | Q30420372 | ||
| High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. | Q30570557 | ||
| A method for identification of HIV gp140 binding memory B cells in human blood | Q33394829 | ||
| Improvements to the percolator algorithm for Peptide identification from shotgun proteomics data sets | Q33433611 | ||
| Host cell factors in HIV replication: meta-analysis of genome-wide studies | Q33455551 | ||
| HIV's evasion of the cellular immune response | Q33683334 | ||
| Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins | Q33806056 | ||
| Generation of human monoclonal antibodies to human immunodeficiency virus | Q33841011 | ||
| Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. | Q34060035 | ||
| Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies | Q34229664 | ||
| Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection | Q34242229 | ||
| Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders | Q34254502 | ||
| Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells | Q34291056 | ||
| Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation | Q34309493 | ||
| TorsinA in the nuclear envelope | Q34336308 | ||
| The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. | Q34341843 | ||
| The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. | Q34342352 | ||
| Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. | Q34434854 | ||
| Fluorescent proteins as proteomic probes. | Q34450046 | ||
| Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors | Q34507124 | ||
| CD4-induced activation in a soluble HIV-1 Env trimer | Q34510675 | ||
| Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. | Q34544718 | ||
| Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions | Q34775632 | ||
| Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals | Q34962766 | ||
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 | ||
| Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. | Q35192782 | ||
| The Notch signalling system: recent insights into the complexity of a conserved pathway | Q35206852 | ||
| Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. | Q35554495 | ||
| Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque | Q35647701 | ||
| Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells | Q35829884 | ||
| Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding | Q35857416 | ||
| Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. | Q35873067 | ||
| The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells | Q35888172 | ||
| Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling | Q36078480 | ||
| Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. | Q37072702 | ||
| The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions | Q37099851 | ||
| Dynamics of HIV-1 recombination in its natural target cells | Q37356815 | ||
| Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors | Q37392831 | ||
| Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission | Q37397841 | ||
| MHC class I antigen presentation: learning from viral evasion strategies | Q37508563 | ||
| Mechanisms of enhanced HIV spread through T-cell virological synapses | Q38070789 | ||
| Structural and functional mechanisms of CRAC channel regulation | Q38256949 | ||
| Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins | Q39206787 | ||
| Aurora B-dependent regulation of class IIa histone deacetylases by mitotic nuclear localization signal phosphorylation | Q39301935 | ||
| Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization | Q39305772 | ||
| Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. | Q39582953 | ||
| A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure | Q39588870 | ||
| Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes | Q39870640 | ||
| Infectivity and neutralization of simian immunodeficiency virus with FLAG epitope insertion in gp120 variable loops | Q40096483 | ||
| Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies | Q40106699 | ||
| Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. | Q40306250 | ||
| Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines | Q40485825 | ||
| The Torsin Activator LULL1 Is Required for Efficient Growth of Herpes Simplex Virus 1. | Q41186697 | ||
| Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif | Q41897467 | ||
| Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif. | Q42152378 | ||
| Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens | Q42170072 | ||
| Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. | Q42282750 | ||
| CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency | Q42573954 | ||
| I-DIRT, a general method for distinguishing between specific and nonspecific protein interactions | Q42670112 | ||
| Inefficient human immunodeficiency virus replication in mobile lymphocytes | Q42957159 | ||
| The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells. | Q42991263 | ||
| CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | Q43239447 | ||
| Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques | Q47213978 | ||
| DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity. | Q52672558 | ||
| gp41: HIV's shy protein | Q56888060 | ||
| The Tumor Suppressor Ikaros Shapes the Repertoire of Notch Target Genes in T Cells | Q62985341 | ||
| Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies | Q72146275 | ||
| Multiple epitope tagging of expressed proteins for enhanced detection | Q73686669 | ||
| Genome-scale RNAi screen for host factors required for HIV replication | Q79769455 | ||
| P433 | issue | 7 | |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 16068 | |
| P577 | publication date | 2016-05-23 | |
| P1433 | published in | Nature Microbiology | Q23022567 |
| P1476 | title | HIV-host interactome revealed directly from infected cells | |
| P478 | volume | 1 |
| Q27980653 | Advances in Zika Virus Research: Stem Cell Models, Challenges, and Opportunities |
| Q61443390 | Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing |
| Q59842331 | CRL4 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling |
| Q47271003 | Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein |
| Q98390836 | Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality |
| Q47225302 | Dissection of affinity captured LINE-1 macromolecular complexes. |
| Q40083777 | Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring. |
| Q55513488 | Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation. |
| Q54232567 | HIV Vaccination: A Roadmap among Advancements and Concerns. |
| Q37708303 | Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function |
| Q30398955 | In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells |
| Q38812665 | Methods, Tools and Current Perspectives in Proteogenomics |
| Q97067564 | Network-Based Analysis of OMICs Data to Understand the HIV-Host Interaction |
| Q64078058 | Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection |
| Q39120670 | Proteomics Tracing the Footsteps of Infectious Disease |
| Q39203410 | Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases. |
Search more.